<DOC>
	<DOCNO>NCT00873652</DOCNO>
	<brief_summary>The UK immunisation guideline recommend child immunise accelerated course hepatitis B vaccine ( i.e . vaccination 0 , 1 , 2 12 month ) receive additional booster dose vaccine later childhood ( usually 3 1/2 year age ) . The primary objective study assess proportion child 'protective ' concentration ( 10mIU/ml ) hepatitis B specific antibody booster dose hepatitis B vaccine .</brief_summary>
	<brief_title>Observational Study Immune Response Hepatitis B Childhood Booster</brief_title>
	<detailed_description>This observational , open label study child immunise infancy Hepatitis B virus ( HBV ) , evaluate persistence immunity immune response schedule booster dose Hepatitis B vaccine . Children eligible/overdue pre school HBV vaccine booster identify review clinical record John Radcliffe Hospital . The parents/legal guardian child write advised child receive/ receive booster dose HBV vaccine . This letter also inform parents/ legal guardian option participate study look persistence HBV vaccine induce antibody early childhood response booster dose HBV vaccine , study conduct Oxford Vaccine Group participant ' home . Parents advise wish take part research study arrange contact GP discuss whether child require booster dose hepatitis B vaccine . For participant study consist two visit four week interval ( visit 1 visit 2 ) . If parents/guardians sign consent form medical immunisation history take medical examination undertaken indicate . If exclusion criterion identify , child enrol study . A 6ml blood sample take child single booster dose Hepatitis B vaccine administer . For child receive booster dose vaccine GP , practice nurse child health department inform . If child also due pre−school booster vaccine ( 4 1 Diphtheria , tetanus , tetanus polio vaccine , combine Hib−MenC vaccine combine measles , mumps , rubella vaccine ( MMR ) ) also offer , form part study assessment . At second visit follow confirmation ongoing consent study first eligibility inclusion check along occurrence serious adverse event , 6mls blood drawn participant . Blood sample use antibody analysis ELISA .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Parent/guardian willing able give inform consent participation study . Male Female , age 3 year 4 month . Commenced Hepatitis B post exposure prophylaxis birth . Able ( Investigators opinion ) willing comply study requirement . Willing allow General Practitioner consultant , appropriate , notified participation study . Parent/guardian willing able give inform consent participation study . The child currently enrol interventional research study History confirm anaphylactic reaction previous dose hepatitis B contain vaccine confirm reaction component vaccine Evidence infection HBV previous blood test . Previous receipt booster dose HBV vaccine within 2 year prior study enrolment . Significant renal hepatic impairment . Participant terminally ill. Any significant disease disorder , opinion Investigator , may either put patient/participant risk participation study , may influence result study , patient/participant 's ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>41 Months</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Hepatitis B vaccine</keyword>
	<keyword>Booster dose</keyword>
	<keyword>Persistence</keyword>
	<keyword>Immune response</keyword>
	<keyword>Healthy child</keyword>
</DOC>